This article focuses on a cross-sectional serologic study conducted among healthcare workers (HCWs) in a tertiary care hospital in Taiwan, conducted from August 2022 to February 2023. The study was to evaluate the antibody responses to COVID-19 vaccination against Omicron subvariants BA.1, BA.4, and BA.5, especially considering the variations in prior exposure to the virus…